The hallmarks of successful anticancer immunotherapy

Area of Science:

• Oncology
• Immunology
• Genomics

Background:

• Cancer immunotherapy offers revolutionary treatment potential but benefits only a subset of patients.
• Current immunotherapies are costly and linked to significant toxicities, necessitating predictive biomarkers.
• Understanding factors influencing immunotherapy response is critical for clinical application.

Purpose of the Study:

• To outline the essential characteristics of successful anticancer immunotherapy.
• To identify key predictive biomarkers for patient response to immunotherapy.

Main Methods:

• Review of preclinical and clinical studies on cancer immunotherapy.
• Analysis of genomic, immune, and microenvironmental factors influencing treatment outcomes.
• Synthesis of data to define hallmarks of effective immunotherapy.

Main Results:

• Tumor genomic configuration, including neoantigen load and specific mutations, impacts immunotherapy sensitivity.
• Immune infiltrate characteristics (type, density, localization, function) are critical for anticancer immunity.
• Tumor microenvironment features (vasculature, stroma) and systemic factors (gut microbiota) significantly influence response.

Conclusions:

• Successful immunotherapy relies on a complex interplay of tumor, immune, and host factors.
• Identifying robust predictive biomarkers is essential to optimize patient selection and treatment efficacy.
• Further research into these hallmarks will advance personalized cancer immunotherapy.